New blood test to screen for secondary heart attack
A blood test that quickly and easily detects whether a person is at risk of a secondary heart attack is being developed by scientists at the Baker Heart and Diabetes Institute...
List view / Grid view
Biomarkers are a naturally occurring molecule, gene, or characteristic by which a particular disease can be identified.
A blood test that quickly and easily detects whether a person is at risk of a secondary heart attack is being developed by scientists at the Baker Heart and Diabetes Institute...
Researchers have identified a novel imaging biomarker, which has been found to be able to predict all-cause and cardiac mortality...
Scientists at Penn State find that heartbeat irregularities connected to brain activity abnormalities may pave the way to predict onset of epilepsy in certain patients…
A team of neuropathologists worked together to show that the impairments affecting mitochondria also affect neighbouring organelles...
Breath tests analysing organic compounds in exhaled breath could be used as a new diagnostic tool for pancreatic cancer...
A protein identified in the signalling pathway for haemoglobin production has been identified as a possible target to treat sickle cell disease (SCD)...
Approach could improve understanding of immune system recovery in people treated for HIV infection...
IGF-1 activated by p38 may be a therapeutic target
Researchers use data science and genomics to help determine best treatment options for specific bladder cancers...
Your comprehensive guide to multiplex and single protein detection...
For lead optimisation, target-based assays are still the most affordable means of rapidly performing fast iterations and remain core to screening. However, the desire for biological relevance is driving ongoing growth in cell-based assays.
The Alzheimer’s Association have published a study wherein a model estimates the lifetime risk of an individual developing Alzheimer’s disease dementia. The risk varies with such factors as age and gender, and crucially takes account of preclinical biological changes.
Scientists have identified the cell types underlying schizophrenia, the findings offer a roadmap for the development of new therapies to target the condition...
A new diagnostic test developed by researchers at UC San Diego shows promise for detecting pancreatic cancer earlier...
Euro Metabolomics 2018 will be a platform to investigate on recent research and advancements that can be useful to the researchers.